Read More

Why BioRestorative Therapies Stock Is Up Today

BioRestorative Therapies presented the data at the Orthopaedic Research Society 2024 Annual Meeting on Sunday and hosted a webcast and slideshow to present the data to stakeholders on Monday morning before the market open. BioRestorative said data that was collected at weeks 26 and 52 post-injection demonstrated a positive trend compared to baseline.

BRTX

Read More

What’s Going On With Palantir Stock Ahead Of Earnings?

Palantir is set to release its fourth-quarter and fiscal year 2023 financial results after the market close on Monday and will host a webcast to discuss the results at 5:00 p.m. ET the same day. According to estimates from Benzinga Pro, Palantir is expected to report fourth-quarter earnings of 8 cents per share and quarterly revenue of $602.4 million.

PLTR

Read More

Why Intelligent Bio Solutions Shares Are Soaring

Intelligent Bio Solutions shares are moving on very heavy trading volume with more than 46.4 million shares already traded in the session. According to data from Benzinga Pro, the stock has a float of only 726,316 shares after the stock effected a 1-for-12 reverse split on Monday. Intelligent Bio Solutions shares have a significant amount of short interest. 45.66% of shares being sold short which, when combined with the heavy trading volume, may be contributing to the stock's large move on Friday.

INBS

Read More

What’s Going On With Bitcoin Miners Marathon Digital and Hut 8 Stock?

Marathon Digital and Hut 8 made separate announcements stating an agreement was signed on Jan. 30 that will terminate Hut 8 operator of these sites and transition the operational responsibilities to Marathon. Hut 8 will continue to provide managed services and conduct self-mining activities at the two mining sites through April 30. A termination fee of $13.568 million will be paid to Hut 8 within 30 days of the termination date.

BTC

Read More

Why Cimpress Stock Is Up After Earnings

Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.1 million by 3.28% and represents a 9% increase over sales of $845.20 million the same period last year.

CMPR